UK Office of Research Integrity

Menu

ORI Home Page

For archived highlights, click on the year of your choice below:

[Note some links in these archived pages could be outdated. To ensure you have access to the most recent resource, visit ORI's current web pages.]

Click here for free Acrobat Reader software, needed for opening PDF links.

What's New? (2017)

This page offers news-worthy topics, helpful regulatory tips, and updates to IRB/ORI policy, procedures, and guidelines for IRB Members and others involved in human research in the year 2017. Note that due to the nature of web page evolution, some links may be broken. For the most current document links, search for the name of the document using the following search tool:

In order to receive electronic issues of the IRB Review Newsletter, or to receive a hard copy of past issues, contact the Office of Research Integrity at 859-323-2446 or e-mail Belinda.Smith@uky.edu and provide your name, e-mail address, department, campus address and phone number.

To jump to a month, click on your choice below:

February
June
July
August 
September
October 
November
December

 

December

 

November

Back to Top

October

 

September

 

August


July

 

 

June

Back to Top

May

5/23/17: IRB Review Newsletter [PDF]

  • E-IRB Submission Pilot Progress: EXEMPTION SUBMISSIONS GOING LIVE June 21, 2017!
  • FDA & NIH Release Final Electronic Template for Clinical Trial Protocols
  • Registration open for OHRP 2-day Research Community Forum (9/6 - 9/7/17, Northern KY Convention Center)

Back to Top

April

4/17/17: IRB Review Newsletter [PDF]

  • Updates to Human Subject Research Courses on CITI
  • E-IRB Pilot Phase
  • Future Education Events

March

3/16/17: IRB Review Newsletter [PDF]

  • HHS issues a New Common Rule, but is it here to stay?

Back to Top

February

 

 

January

1/11/17: IRB Review Newsletter [PDF]

  • New National Research Participant Website
  • Pre-screening Potential Subjects Using REDCap
  • Human Subject Protection Update: What the Future Holds
  • Increase in One-Time Fee to Industry-Sponsors of Clinical Trials

Back to Top